Diagnostics at the frontline: using the Public Accounts Committee report to catalyse the UK’s antimicrobial resistance diagnostics strategy
Between 2020 and 2024, the UK Government spent £567 million1 on its programme for tackling the growing threat of antimicrobial resistance (AMR), of which £543 million was allocated to the Department of Health and Social Care, National Health Service England, and UK Health Security Agency. On June 13, 2025, the UK Public Accounts Committee (PAC), which scrutinises government spending, published a review evaluating the effectiveness of this spending to address AMR risks through the measures set out in the national action plan (NAP).2
Authors
- Andrew C. Singer (ORCID: https://orcid.org/0000-0003-4705-6063)
- Mark Bradley (ORCID: https://orcid.org/0000-0001-7893-1575)
- Marieke Emonts (ORCID: https://orcid.org/0000-0002-2822-3527)
- Jessica Mitchell (ORCID: https://orcid.org/0000-0002-2892-4630)
- Nichola J. Hawkins (ORCID: https://orcid.org/0000-0003-3389-0436)
- Seshasailam Venkateswaran
Institutions
- National Institute of Agricultural Botany (GB)
- Queen Mary University of London (GB)
- UK Centre for Ecology & Hydrology (GB)
- Newcastle upon Tyne Hospital (GB)
- NIHR Newcastle Biomedical Research Centre (GB)
- Great North Children's Hospital (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- The Lancet Microbe
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.lanmic.2025.101243
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00